Educational Activity

Page 18

Posts about this type

Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances

May 15, 2007

Peter J. Weiden, John W. Newcomer

Educational Activity

Translating the Evidence on Atypical Depression Into Clinical Practice

April 15, 2007

Mark Hyman Rapaport, Michael E. Thase

Educational Activity

Treating DSM-IV Depression with Atypical Features

April 15, 2007

Jonathan W. Stewart, Michael E. Thase

Educational Activity

Challenges and Solutions to Integrating Mental and Physical Health Care

April 15, 2007

Benjamin G. Druss, John W. Newcomer

Educational Activity

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

March 15, 2007

Pierre Blier, Martin B. Keller, Mark H. Pollack, et al

Educational Activity

Comparing Safety and Tolerability of Antipsychotic Treatment

March 15, 2007

John W. Newcomer, Jeffrey A. Lieberman

Educational Activity

Cost-Effectiveness Measures, Methods, and Policy Implications From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia

February 15, 2007

Robert A. Rosenheck, Jeffrey A. Lieberman

Educational Activity

Effectiveness of Antipsychotic Drugs in Patients With Chronic Schizophrenia: Efficacy, Safety, and Cost Outcomes of CATIE and Other Trials

February 15, 2007

Jeffrey A. Lieberman

Educational Activity

The History of Atypical Depression

February 15, 2007

Understand the history of atypical depression and differentiate between the clinical characteristics of typical and atypical depression.

Jonathan R. T. Davidson, Michael E. Thase

Educational Activity

Treating Depression Complicated by Comorbid Medical Illness or Anxiety

January 15, 2007

Madhukar H. Trivedi, Anita H. Clayton, Ellen Frank

Educational Activity

The Art and Science of Switching Antipsychotic Medications, Part 2

January 15, 2007

Peter J. Weiden, Alexander L. Miller, Tim J. Lambert, et al

Educational Activity

New Directions in the Treatment of Atypical Depression

December 15, 2006

Michael E. Thase

Educational Activity

Long-Term Treatment of Bipolar Disorder

December 15, 2006

Read a review discussing discusses long-term treatment strategies for bipolar disorder and functional outcome measures associated with these treatments.

Paul E. Keck

Educational Activity

Bipolar & Schizophrenia Risk Factors

November 15, 2006

Read an article about how patients with bipolar disorder and schizophrenia are vulnerable to developing key modifiable risk factors.

John W. Newcomer

Educational Activity

The Art and Science of Switching of Antipsychotic Medications, Part 1

November 15, 2006

Peter J. Weiden, Allan H. Young, Peter F. Buckley

Educational Activity

Cognitive and Functional Effects of Atypical Antipsychotic Medications

October 16, 2006

Philip D. Harvey

Educational Activity

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

October 16, 2006

Michael F. Green

Educational Activity

Neurobiology and the Natural History of Schizophrenia

October 1, 2006

Jeffrey A. Lieberman

Educational Activity

The Neurobiology of Schizophrenia

September 15, 2006

Read a summary of the neurobiology and treatment of cognition in schizophrenia.

Carol A. Tamminga

Educational Activity

Neuroprotection in Schizophrenia

September 15, 2006

L. Fredrik Jarskog, Jeffrey A. Lieberman

Educational Activity

Update on Bipolar Disorder and Substance Abuse: Recent Findings and Treatment Strategies

September 15, 2006

Michael J. Ostacher, Gary S. Sachs

Educational Activity

Comorbid Schizophrenia and Substance Abuse

September 15, 2006

Alan I. Green, E. Sherwood Brown

Educational Activity

Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia

August 1, 2006

Philip D. Harvey

Educational Activity

Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder

August 1, 2006

Dolores Malaspina

« 1 … 16 17 18 19 »

Educational Activity

Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances

Translating the Evidence on Atypical Depression Into Clinical Practice

Treating DSM-IV Depression with Atypical Features

Challenges and Solutions to Integrating Mental and Physical Health Care

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

Comparing Safety and Tolerability of Antipsychotic Treatment

Cost-Effectiveness Measures, Methods, and Policy Implications From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia

Effectiveness of Antipsychotic Drugs in Patients With Chronic Schizophrenia: Efficacy, Safety, and Cost Outcomes of CATIE and Other Trials

The History of Atypical Depression

Treating Depression Complicated by Comorbid Medical Illness or Anxiety

The Art and Science of Switching Antipsychotic Medications, Part 2

New Directions in the Treatment of Atypical Depression

Long-Term Treatment of Bipolar Disorder

Bipolar & Schizophrenia Risk Factors

The Art and Science of Switching of Antipsychotic Medications, Part 1

Cognitive and Functional Effects of Atypical Antipsychotic Medications

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

Neurobiology and the Natural History of Schizophrenia

The Neurobiology of Schizophrenia

Neuroprotection in Schizophrenia

Update on Bipolar Disorder and Substance Abuse: Recent Findings and Treatment Strategies

Comorbid Schizophrenia and Substance Abuse

Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia

Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder

ELSEWHERE:

FOLLOW US:

Educational Activity

Posts about this type

Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances

Translating the Evidence on Atypical Depression Into Clinical Practice

Treating DSM-IV Depression with Atypical Features

Challenges and Solutions to Integrating Mental and Physical Health Care

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

Comparing Safety and Tolerability of Antipsychotic Treatment

Cost-Effectiveness Measures, Methods, and Policy Implications From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia

Effectiveness of Antipsychotic Drugs in Patients With Chronic Schizophrenia: Efficacy, Safety, and Cost Outcomes of CATIE and Other Trials

The History of Atypical Depression

Treating Depression Complicated by Comorbid Medical Illness or Anxiety

The Art and Science of Switching Antipsychotic Medications, Part 2

New Directions in the Treatment of Atypical Depression

Long-Term Treatment of Bipolar Disorder

Bipolar & Schizophrenia Risk Factors

The Art and Science of Switching of Antipsychotic Medications, Part 1

Cognitive and Functional Effects of Atypical Antipsychotic Medications

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

Neurobiology and the Natural History of Schizophrenia

The Neurobiology of Schizophrenia

Neuroprotection in Schizophrenia

Update on Bipolar Disorder and Substance Abuse: Recent Findings and Treatment Strategies

Comorbid Schizophrenia and Substance Abuse

Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia

Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles